Cargando…

Pirfenidone in patients with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis

To evaluate the efficacy of pirfenidone in patients with rapidly progressive interstitial lung disease (RPILD) related to clinically amyopathic dermatomyositis (CADM), we conducted an open-label, prospective study with matched retrospective controls. Thirty patients diagnosed with CADM-RPILD with a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ting, Guo, Li, Chen, Zhiwei, Gu, Liyang, Sun, Fangfang, Tan, Xiaoming, Chen, Sheng, Wang, Xiaodong, Ye, Shuang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018967/ https://www.ncbi.nlm.nih.gov/pubmed/27615411 http://dx.doi.org/10.1038/srep33226

Ejemplares similares

Fatal rapidly progressive interstitial lung disease in a patient with amyopathic dermatomyositis
por: Mobeireek, Abdullah, et al.
Publicado: (2021)

Research progress on amyopathic dermatomyositis associated with interstitial lung disease
por: Bai, Yu, et al.
Publicado: (2020)

Risk factors of interstitial lung diseases in clinically amyopathic dermatomyositis
por: Gan, Yu-Zhou, et al.
Publicado: (2020)

Anti-MDA5 Associated Clinically Amyopathic Dermatomyositis With Rapidly Progressive Interstitial Lung Disease
por: Tavakolian, Kameron, et al.
Publicado: (2022)

A Case of Sarcoidosis with Interstitial Lung Disease Mimicking Clinically Amyopathic Dermatomyositis and Rapidly Progressive Interstitial Lung Disease
por: Sato, Shinji, et al.
Publicado: (2014)

COVID-19 or clinical amyopathic dermatomyositis associated rapidly progressive interstitial lung disease? A case report
por: Cao, Mengke, et al.
Publicado: (2020)

Clinically Amyopathic Dermatomyositis With Rapid Progressive Interstitial Lung Disease Diagnosed in a Patient on Extracorporeal Membrane Oxygenation
por: Al-Husayni, Faisal, et al.
Publicado: (2022)

Clinically Amyopathic Dermatomyositis with Interstitial Pneumonia That Was Successfully Treated with Plasma Exchange
por: Yagishita, Mizuki, et al.
Publicado: (2018)

Cytokine profiles of amyopathic dermatomyositis with interstitial lung diseases treated with mycophenolate
por: Hayashi, Masachika, et al.
Publicado: (2017)

Panniculitis associated with amyopathic dermatomyositis
por: Azevedo, Paula de Oliveira, et al.
Publicado: (2018)

Pruritus in patients with amyopathic dermatomyositis
por: Poddighe, Dimitri, et al.
Publicado: (2019)

Clinically Amyopathic Juvenile Dermatomyositis
por: Yıldırım, Deniz Gezgin, et al.
Publicado: (2023)

Fibrocellular non‐specific interstitial pneumonia with favourable prognosis in clinically amyopathic dermatomyositis
por: Yoshizawa, Takahiro, et al.
Publicado: (2016)

A Case of Polymyxin b-Immobilized Fiber Column Treatment for Rapidly Progressive Interstitial Pneumonia Associated with Clinically Amyopathic Dermatomyositis
por: Sasaki, Oh, et al.
Publicado: (2013)

Case Report: Extracorporeal Membrane Oxgenation for Rapidly Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis in a Post-partum Woman
por: Gu, Qiao, et al.
Publicado: (2021)

Amyopathic dermatomyositis with diffuse lung disease
por: Bandi, Sumeera, et al.
Publicado: (2020)

Acute lyme infection presenting with amyopathic dermatomyositis and rapidly fatal interstitial pulmonary fibrosis: a case report
por: Nguyen, Hien, et al.
Publicado: (2010)

Double anti-PL-7 and anti-MDA-5 positive Amyopathic Dermatomyositis with rapidly progressive interstitial lung disease in a Hispanic patient
por: Li, Zi Ying, et al.
Publicado: (2020)

Correlation between disease activity and serum ferritin in clinically amyopathic dermatomyositis with rapidly-progressive interstitial lung disease: a case report
por: Yamada, Kazuhiro, et al.
Publicado: (2018)

Clinically Amyopathic Dermatomyositis Caused by a Tattoo
por: Han, Bing, et al.
Publicado: (2018)

COVID-19 vaccine: Vaccine reaction, amyopathic dermatomyositis and interstitial lung disease: case report
Publicado: (2021)

Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study
por: Ikeda, Satoshi, et al.
Publicado: (2015)

Rapidly progressive melanoma differentiation–associated protein 5–positive amyopathic dermatomyositis in an HIV-positive patient
por: Sharma, Ashutosh, et al.
Publicado: (2017)

Clinical effects of direct hemoperfusion using a polymyxin B-immobilized fiber column in clinically amyopathic dermatomyositis-associated rapidly progressive interstitial pneumonias
por: Okabayashi, Hiroko, et al.
Publicado: (2017)

The Serum Ferritin Level Is Associated with the Treatment Responsivity for Rapidly Progressive Interstitial Lung Disease with Amyopathic Dermatomyositis, Irrespective of the Anti-MDA5 Antibody Level
por: Osawa, Takeshi, et al.
Publicado: (2017)

Slowly progressive interstitial lung disease preceding typical dermatomyositis symptoms in anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis
por: Isono, Taisuke, et al.
Publicado: (2021)

Paget's Disease of the Breast in a Patient with Amyopathic Dermatomyositis
por: Yasar, Sirin, et al.
Publicado: (2012)

A Case of Amyopathic Dermatomyositis with Pneumomediastinum and Subcutaneous Emphysema
por: Gürün Kaya, Aslıhan, et al.
Publicado: (2015)

Pneumomediastinum in MDA5-associated clinically amyopathic dermatomyositis
por: Kotsiou, Ourania S., et al.
Publicado: (2017)

Clinically amyopathic dermatomyositis during the COVID-19 pandemic
por: Kitamura, Masakazu, et al.
Publicado: (2021)

Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split?
por: Ikeda, Satoshi, et al.
Publicado: (2015)

Fast-Onset Diffuse Interstitial Lung Disease in Anti-MDA5 Antibodies-Associated Amyopathic Dermatomyositis
por: Aissaoui, Houari, et al.
Publicado: (2021)

Case Report: Treatment of Anti-MDA5-Positive Amyopathic Dermatomyositis Accompanied by a Rapidly Progressive Interstitial Lung Diseases With Methylprednisolone Pulse Therapy Combined With Cyclosporine A and Hydroxychloroquine
por: Zhang, Qia-Chun, et al.
Publicado: (2020)

Lung histopathological pattern in a survivor with rapidly progressive interstitial lung disease and anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis
por: Suzuki, Atsushi, et al.
Publicado: (2016)

Tumoral Calcinosis as an Initial Complaint of Juvenile-Onset Amyopathic Dermatomyositis
por: Doh, Eun Jin, et al.
Publicado: (2016)

A Rare Case of MDA-5-Positive Amyopathic Dermatomyositis with Rapidly Progressive Interstitial Lung Disease Following COVID-19 mRNA Vaccination — a Case Report
por: Wang, Shuwei, et al.
Publicado: (2022)

Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis Complicated by Unilateral Right-sided Interstitial Lung Disease
por: Kori, Mayuko, et al.
Publicado: (2020)

Clinically amyopathic dermatomyositis with interstitial lung disease double-positive for anti-MDA5 and anti-PL12 antibodies
por: Hiramatsu, Toshiya, et al.
Publicado: (2022)

Amyopathic Dermatomyositis Associated with Histopathological Findings of Organizing Pneumonia and Pulmonary Vasculitis
por: Lim, Jeong Uk, et al.
Publicado: (2017)

Juvenile Clinically Amyopathic Dermatomyositis: A Case Report and Review of Literature
por: JAVADI PARVANEH, Vadood, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hn78kn57tmh12ui4qr31f39nec